Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anixa Biosciences IncANIX · Entity 6698 | Director | January 05, 2026 | January 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anixa Biosciences Inc
Report date January 05, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $3.18 · Expires 2036-01-05 | Direct | 25,000 |
Reported balance
After 2026-01-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-05 · Grant · Acquired 25,000 · Balance 25,000 F1: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2: The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2: The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 05, 2026 Filed Jan 6, 2026 19:41 UTC | Anixa Biosciences Inc ANIX · Entity 6698 | GrantEmployee Stock Option · Derivative | 25,000 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001493152-26-000687 · ownership.xml · derivative · entry 1 Gottschalk Emily · CIK 0001791108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2036-01-05 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2026. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 17:40 UTC | Anixa Biosciences Inc ANIX · Entity 6698 | GrantEmployee Stock Option · Derivative | 25,000 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0001493152-25-000315 · ownership.xml · derivative · entry 1 Gottschalk Emily · CIK 0001791108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-01-02 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2025. Read SEC document |
| January 12, 2024 Filed Jan 16, 2024 19:07 UTC | Anixa Biosciences Inc ANIX · Entity 6698 | GrantEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $4.39 | $0.00 |
DisclosureSEC source: 0001493152-24-002530 · ownership.xml · derivative · entry 1 Gottschalk Emily · CIK 0001791108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-01-12 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2024. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 20:58 UTC | Anixa Biosciences Inc ANIX · Entity 6698 | GrantEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0001493152-23-000424 · ownership.xml · derivative · entry 1 Gottschalk Emily · CIK 0001791108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2033-01-03 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2023. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 16:15 UTC | Anixa Biosciences Inc ANIX · Entity 6698 | GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001493152-22-006625 · ownership.xml · derivative · entry 1 Gottschalk Emily · CIK 0001791108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-03-10 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in twelve (12) equal monthly installments beginning March 31, 2022. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 12:45 UTC | Anixa Biosciences Inc ANIX · Entity 6698 | PurchaseCommon Stock | 20,065 | $3.96 | $79,457.40 |
DisclosureSEC source: 0001493152-21-017013 · ownership.xml · nonDerivative · entry 1 Gottschalk Emily · CIK 0001791108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,665 Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 17:00 UTC | Anixa Biosciences Inc ANIX · Entity 6698 | GrantEmployee Stock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $4.02 | $0.00 |
DisclosureSEC source: 0001493152-21-013455 · ownership.xml · derivative · entry 1 Gottschalk Emily · CIK 0001791108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-06-01 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in twelve (12) equal monthly installments beginning June 30, 2021. Read SEC document |
| April 23, 2021 Filed Apr 23, 2021 12:04 UTC | Anixa Biosciences Inc ANIX · Entity 6698 | PurchaseCommon Stock | 10,000 | $4.49 | $44,900.00 |
DisclosureSEC source: 0001493152-21-009519 · ownership.xml · nonDerivative · entry 1 Gottschalk Emily · CIK 0001791108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,600 Read SEC document |
| March 25, 2021 Filed Mar 26, 2021 09:41 UTC | Anixa Biosciences Inc ANIX · Entity 6698 | PurchaseCommon Stock | 15,600 | $4.88 | $76,128.00 |
DisclosureSEC source: 0001493152-21-006891 · ownership.xml · nonDerivative · entry 1 Gottschalk Emily · CIK 0001791108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,600 Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 16:27 UTC | Anixa Biosciences Inc ANIX · Entity 6698 | GrantEmployee Stock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001513162-20-000172 · primary_doc.xml · derivative · entry 1 Gottschalk Emily · CIK 0001791108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-08-13 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in twelve (12) equal monthly installments beginning August 31, 2020. Read SEC document |
| October 23, 2019 Filed Oct 24, 2019 19:55 UTC | Anixa Biosciences Inc ANIX · Entity 6698 | GrantEmployee Stock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $3.87 | $0.00 |
DisclosureSEC source: 0001513162-19-000225 · primary_doc.xml · derivative · entry 1 Gottschalk Emily · CIK 0001791108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2029-10-23 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in twelve (12) equal monthly installments beginning November 30, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.